Lee Johnson Capital Management, LLC Abb Vie Inc. Transaction History

Lee Johnson Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $70,538 - $84,593	510 Added 4.88%	10,957 $1.77 Million
Q3 2022 Oct 28, 2022	BUY	$134.21 - $153.93 $30,331 - $34,788	226 Added 2.21%	10,447 $1.4 Million
Q2 2022 Jul 13, 2022	BUY	$137.62 - $174.96 $90,003 - $114,423	654 Added 6.84%	10,221 $1.57 Million
Q1 2022 Apr 26, 2022	BUY	$131.98 - $163.75 $32,071 - $39,791	243 Added 2.61%	9,567 $1.55 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $1 Million - $1.27 Million	9,324 New	9,324 $1.26 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Lee Johnson Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Lee Johnson Capital Management, LLC with notifications on news.